Overview
- 41 inspections across 37 sites are on record.
- 170 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2018-01-11.
At a glance
Inspections
41
Sites
37
Observations
170
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Bimeda Pomona Inc. | 11 Jan 2018 | Animal Drugs & Feeds | View 483 → |
| Baxter Healthcare Corporation | 17 Nov 2017 | Human Drugs | View 483 → |
| Partner Therapeutics, Inc. | 18 Nov 2016 | Human Drugs | On file |
| Eurofins Pharma Quality Control | 13 Jul 2016 | Human Drugs | |
| Bend Research Inc | 3 Jun 2016 | Human Drugs | View 483 → |
Sites inspected
Bimeda Pomona Inc.Pomona, United States1 insp.
Baxter Healthcare CorporationMarion, United States1 insp.
Partner Therapeutics, Inc.Lynnwood, United States1 insp.
Eurofins Pharma Quality ControlCourtaboeuf CEDEX, France1 insp.
Bend Research IncBend, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Anita Narula7 shared
Thomas J Arista5 shared
Tracy K Li3 shared
Phillip M Pontikos3 shared
Marijo B Kambere3 shared
Christopher R Czajka3 shared
Seneca D Toms2 shared
Barbara J Breithaupt2 shared
Nancy A Saxenian Emmons2 shared
Mai X Huynh1 shared
Full investigator report
Get the verbatim findings behind Robert D Tollefsen's 170 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site